^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ATLCAR.CD30.CCR4 cells

    i
    Other names: ATLCAR.CD30.CCR4 cells
    Associations
    News
    Trials
    Company:
    UNC Lineberger Comprehensive Cancer Center
    Drug class:
    CD30-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials